Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel Coronavirus Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06130345
What this trial is testing

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 15,196,685
Not applicableUnknownNCT06085911
What this trial is testing

RCT Long COVID-19 Rehabilitation

Who this might be right for
RehabilitationPost-Acute COVID-19 SyndromePost-Infectious Disorders
University Hospital of North Norway 60
Large-scale testing (Phase 3)Study completedNCT04546581
What this trial is testing

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Who this might be right for
COVIDCOVID-19SARS-CoV-2+1 more
University of Minnesota 593
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Not applicableStudy completedNCT04606407
What this trial is testing

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Who this might be right for
Viral PneumoniaNitric OxideRespiratory Disease+4 more
Beyond Air Inc. 40
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247
Not applicableStudy completedNCT05621239
What this trial is testing

Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Who this might be right for
COVID-19
Pfizer 260
Testing effectiveness (Phase 2)Study completedNCT04407507
What this trial is testing

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms

Who this might be right for
COVID-19
Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V. 66
Not applicableUnknownNCT04817371
What this trial is testing

Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.

Who this might be right for
Covid19
Hopital Foch 192
Large-scale testing (Phase 3)UnknownNCT05445934
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 1,188
Not applicableStudy completedNCT04344977
What this trial is testing

Collection of Anti-SARS-CoV-2 Immune Plasma

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 151
Not applicableStudy completedNCT05663957
What this trial is testing

EVusheld Assessment reaL wORld Effectiveness in the VA Health System

Who this might be right for
SARS-CoV-2, COVID-19
AstraZeneca 5,814
Not applicableLooking for participantsNCT06482138
What this trial is testing

Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation

Who this might be right for
Covid19Olfactory Dysfunction
Universitaire Ziekenhuizen KU Leuven 240
Not applicableStudy completedNCT04871633
What this trial is testing

Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore

Who this might be right for
COVID-19
King Edward Medical University 66
Not applicableNot Yet RecruitingNCT06911476
What this trial is testing

From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19

Who this might be right for
PASC Post Acute Sequelae of COVID 19Long COVIDLong Covid-19+6 more
University Medical Center Groningen 60
Testing effectiveness (Phase 2)Study completedNCT04375397
What this trial is testing

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury

Who this might be right for
CoronaVirus Induced Disease-2019 (COVID-19)
AbbVie 46
Very early researchUnknownNCT05928468
What this trial is testing

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 210
Early research (Phase 1)Study completedNCT05441215
What this trial is testing

Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women

Who this might be right for
Healthy Participants
Pfizer 8
Large-scale testing (Phase 3)UnknownNCT04519125
What this trial is testing

Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Hospital Universitario San Ignacio 950
Next Page